Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹108 Cr.
Stock P/E
19.2
P/B
1.4
Current Price
₹62.9
Book Value
₹ 45.2
Face Value
10
52W High
₹92.3
52W Low
₹ 39.1
Dividend Yield
0%

Crop Life Science Overview

Business

Crop Life Science Ltd. (CLSL) operates in the Pesticides & Agrochemicals sector in India. The company's core business involves the manufacturing, formulation, and marketing of a diverse range of agrochemical products. These products typically include insecticides, fungicides, herbicides, plant growth regulators, and other crop protection chemicals. CLSL aims to provide solutions to farmers for enhancing crop yield and protecting crops from pests and diseases. The company generates revenue by selling these agrochemical products to farmers through a network of distributors and dealers across various agricultural regions.

Revenue Mix

While specific revenue breakdown is not available, companies in this industry typically segment their product offerings into:

Insecticides: For controlling insect pests.

Fungicides: For preventing and treating fungal diseases.

Herbicides: For managing weeds.

Plant Growth Regulators (PGRs) & Bio-stimulants: For enhancing plant growth and development.

Other Crop Protection Products: Including seed treatment chemicals and specialty nutrients.

The revenue mix would depend on the prevalence of specific pest/disease outbreaks, crop cycles, and market demand for each category.

Industry

The Indian Pesticides & Agrochemicals industry is characterized by a mix of large multinational corporations, established domestic players, and numerous smaller regional companies. It is a highly competitive, fragmented market driven by agricultural output, monsoon patterns, and government agricultural policies. Demand is largely seasonal and sensitive to climatic conditions. CLSL, as a domestic player, likely competes on factors such as product efficacy, pricing, brand recognition, and the strength of its distribution network in its target markets. Its positioning would be against both larger, more diversified players and smaller, regional formulators.

MOAT

Without specific details, identifying a strong, durable moat for CLSL is challenging. Potential competitive advantages in this sector could include:

Strong Distribution Network: An extensive and efficient network to reach farmers in rural areas.

Cost Leadership: Efficient manufacturing processes and sourcing leading to competitive pricing.

Brand Loyalty: For specific, effective, and trusted products among farmers.

Regulatory Expertise: Ability to navigate complex registration processes for new molecules or formulations.

Local Market Understanding: Deep knowledge of specific crop patterns, pest issues, and farmer needs in different regions of India.

For a company like CLSL, its local market understanding and established distribution channels are likely its primary advantages.

Growth Drivers

Increasing Food Demand: India's growing population necessitates higher agricultural output, driving demand for crop protection products.

Need for Yield Enhancement: Farmers' increasing awareness and adoption of modern farming practices to improve crop yields and quality.

Government Support & Initiatives: Favorable government policies and subsidies for the agriculture sector.

New Product Launches: Introduction of new, more effective, or environmentally friendly formulations.

Export Opportunities: Potential for exporting agrochemicals to other agricultural economies.

Crop Diversification & Intensification: Changes in cropping patterns leading to varied demand for different agrochemicals.

Risks

Monsoon Dependency: Agricultural output is highly dependent on monsoon patterns, directly impacting demand for agrochemicals.

Regulatory Changes: Strict environmental regulations, bans on certain chemicals, or changes in registration processes can impact product portfolios and operational costs.

Raw Material Price Volatility: Fluctuations in prices of key raw materials derived from crude oil or other chemicals can affect profitability.

Intense Competition: Highly fragmented market leading to pricing pressures and challenges in market share growth.

Counterfeit Products: Presence of spurious products in the market can erode trust and market share.

Pest Resistance & Product Obsolescence: Pests developing resistance to existing chemicals, requiring continuous R&D and new product development.

Environmental Concerns: Increasing scrutiny on the environmental and health impacts of pesticides.

Management & Ownership

Typically, many Indian companies in this sector begin as promoter-driven enterprises. The management quality would depend on their experience in the agrochemical industry, R&D capabilities, operational efficiency, and ability to navigate market dynamics and regulatory changes. Ownership structure often involves a significant promoter holding, with the remaining shares held by institutional investors and the public. The vision and strategic direction are generally influenced by the founding family or core promoter group.

Outlook

CLSL operates in a sector with inherent growth drivers fueled by India's agricultural reliance and need for food security. The ongoing push for better crop yields and farmer awareness provides a foundation for demand for its products. However, the company faces significant challenges from a highly competitive landscape, sensitivity to monsoon patterns, and evolving regulatory environments. Its ability to innovate, expand its distribution network, manage raw material costs, and successfully introduce new products will be crucial for sustained growth. The outlook remains balanced, acknowledging both the considerable market potential in Indian agriculture and the specific operational and environmental risks endemic to the agrochemical industry.

Crop Life Science Share Price

Live · NSE · Inception: 2006
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Crop Life Science Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Crop Life Science Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 131 199 201
Other Income 1 2 2
Total Income 132 201 202
Total Expenditure 119 186 185
Operating Profit 13 15 17
Interest 3 3 5
Depreciation 4 3 5
Exceptional Income / Expenses 0 0 0
Profit Before Tax 6 8 8
Provision for Tax 2 2 2
Profit After Tax 4 6 6
Adjustments 0 0 0
Profit After Adjustments 4 6 6
Adjusted Earnings Per Share 3.4 3.5 3.4

Crop Life Science Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 41 72 77
Minority's Interest 0 4 4
Borrowings 6 6 3
Other Non-Current Liabilities 1 5 5
Total Current Liabilities 56 95 95
Total Liabilities 103 182 184
Fixed Assets 16 39 38
Other Non-Current Assets 0 1 2
Total Current Assets 87 142 144
Total Assets 103 182 184

Crop Life Science Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 1 2
Cash Flow from Operating Activities 2 -8 -2
Cash Flow from Investing Activities -4 -3 -4
Cash Flow from Financing Activities 1 13 4
Net Cash Inflow / Outflow -2 2 -1
Closing Cash & Cash Equivalent 0 2 1

Crop Life Science Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.39 3.51 3.44
CEPS(Rs) 6.48 5.39 6.08
DPS(Rs) 0 0 0
Book NAV/Share(Rs) 33.8 41.85 45.19
Core EBITDA Margin(%) 8.97 6.35 7.75
EBIT Margin(%) 6.76 5.79 6.26
Pre Tax Margin(%) 4.27 4.08 3.89
PAT Margin (%) 3.1 3.03 2.79
Cash Profit Margin (%) 5.93 4.65 5.2
ROA(%) 3.95 4.22 3.06
ROE(%) 10.04 10.72 7.51
ROCE(%) 13.33 13.56 11.35
Receivable days 90.55 100.91 133.34
Inventory Days 72.84 60.65 80.71
Payable days 79.13 90.76 121.49
PER(x) 0 10.47 14.84
Price/Book(x) 0 0.88 1.13
Dividend Yield(%) 0 0 0
EV/Net Sales(x) 0.29 0.46 0.63
EV/Core EBITDA(x) 2.99 6.24 7.31
Net Sales Growth(%) 0 51.35 1
EBIT Growth(%) 0 29.63 9.12
PAT Growth(%) 0 47.77 -6.9
EPS Growth(%) 0 3.58 -2.19
Debt/Equity(x) 0.64 0.44 0.52
Current Ratio(x) 1.55 1.5 1.52
Quick Ratio(x) 1.08 1.08 1
Interest Cover(x) 2.71 3.39 2.64
Total Debt/Mcap(x) 0 0.5 0.46

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +1% — — —
Operating Profit CAGR +13% — — —
PAT CAGR 0% — — —
Share Price CAGR +13% +15% — —
ROE Average +8% +9% +9% +9%
ROCE Average +11% +13% +13% +13%

Crop Life Science Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 70.01 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 29.99 %
# Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
Promoter 70.0170.0170.0170.0170.0170.01
FII 000000
DII 000000
Public 29.9929.9929.9929.9929.9929.99
Others 000000
Total 100100100100100100

Crop Life Science Peer Comparison

Pesticides & Agrochemicals Edit Columns

Crop Life Science Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Crop Life Science Pros & Cons

Pros

  • Company has reduced debt.

Cons

  • Company has a low return on equity of 9% over the last 3 years.
  • Debtor days have increased from 90.76 to 121.49days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp